Basilea Pharmaceutica AG Stock
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
01:30:23 29/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 64.50 CHF | -1.38% |
|
-0.15% | +17.92% |
| 19/08 | Basilea Pharmaceutica Ag Raises Earnings Guidance for the Full Year 2026 | CI |
| 19/08 | Swiss Market Index Closes Higher; Huber+Suhner Shares Drop | MT |
| Market Cap | 800M 990M 853M 730M 1.38B 94.64B 1.38B 9.49B 3.7B 47.77B 3.72B 3.64B 158B | P/E 2026 * |
19x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 650M 804M 693M 593M 1.12B 76.88B 1.12B 7.71B 3.01B 38.81B 3.02B 2.95B 129B | EV / Sales 2026 * |
2.49x | EV / Sales 2027 * | 2.17x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Basilea Pharmaceutica AG
| 1 day | -1.38% | ||
| 1 week | -0.15% | ||
| Current month | +24.28% | ||
| 1 month | +24.52% | ||
| 3 months | +22.86% | ||
| 6 months | +16.85% | ||
| Current year | +17.92% |
| 1 week | 63.4 |  | 66.5 |
| 1 month | 50.4 | | 66.5 |
| Current year | 47.8 | | 66.5 |
| 1 year | 44.7 | | 66.5 |
| 3 years | 32 | | 66.5 |
| 5 years | 29.55 | | 66.5 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/5/26 | Sell | -400 | 0.0030% | |||
| 13/5/26 | Sell | -1,043 | 0.0078% | |||
| 4/5/26 | Sell | 400 | 0.0030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.38% | -0.15% | +39.16% | +33.82% | 990M | |
| -0.78% | -1.42% | +2.49% | +22.78% | 50.47B | |
| -6.00% | -0.75% | +442.41% | +544.39% | 44.56B | |
| -0.24% | +0.74% | +38.69% | +18.02% | 43.08B | |
| -1.55% | -2.07% | +23.08% | +81.47% | 41.7B | |
| -0.31% | -0.83% | +16.15% | +51.42% | 33.21B | |
| -1.79% | -3.24% | +27.00% | +129.56% | 16.77B | |
| -0.58% | -2.12% | - | - | 16.28B | |
| -0.88% | -0.66% | +11.60% | +27.75% | 14.58B | |
| -1.66% | -1.25% | +78.59% | +46.66% | 13.92B | |
| Average | -1.52% | -0.97% | +75.46% | +106.21% | 27.55B | |
| Weighted average by Cap. | -1.70% | -1.06% | +95.49% | +133.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 261M 323M 278M 238M 448M 30.83B 450M 3.09B 1.21B 15.56B 1.21B 1.18B 51.61B | 271M 335M 289M 247M 465M 32B 467M 3.21B 1.25B 16.15B 1.26B 1.23B 53.56B |
| Net income | 53.56M 66.29M 57.12M 48.89M 92.1M 6.34B 92.39M 635M 248M 3.2B 249M 243M 10.6B | 44.43M 54.99M 47.39M 40.56M 76.41M 5.26B 76.65M 527M 206M 2.65B 206M 202M 8.8B |
| Net Debt | -150M -186M -160M -137M -258M -17.75B -259M -1.78B -695M -8.96B -697M -682M -29.72B | -214M -264M -228M -195M -367M -25.28B -369M -2.54B -989M -12.76B -993M -971M -42.31B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | CHF 64.50 | -1.38% | 29,170 |
| 27/08/26 | CHF 65.40 | -0.15% | 42,086 |
| 26/08/26 | CHF 65.50 | +0.31% | 48,673 |
| 25/08/26 | CHF 65.30 | +0.93% | 46,885 |
| 24/08/26 | CHF 64.70 | +0.15% | 64,913 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
